NCT06768489
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06768489
Title A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide or in Combination With Pomalidomide for Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ISR | ESP | AUS

Facility Status City State Zip Country Details
Monash Medical Centre RECRUITING Clayton 3168 Australia Details
St Vincents Hospital Melbourne RECRUITING Fitzroy 3065 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne 3000 Australia Details
Calvary Mater Newcastle Hospital RECRUITING Waratah 2298 Australia Details
Wollongong Hospital RECRUITING Wollongong 2500 Australia Details
Carmel Medical Center RECRUITING Haifa 3436212 Israel Details
Hadassah Medical Center RECRUITING Jerusalem 9112001 Israel Details
Sheba Medical Center RECRUITING Ramat Gan 52621 Israel Details
Tel Aviv Sourasky Medical Center RECRUITING Tel Aviv 64239 Israel Details
VU Medisch Centrum RECRUITING Amsterdam 1081 HV Netherlands Details
Universitair Medisch Centrum Groningen RECRUITING Groningen 9713 GZ Netherlands Details
UMC Utrecht RECRUITING Utrecht 3584 CX Netherlands Details
Hosp. Clinic de Barcelona RECRUITING Barcelona 08036 Spain Details
Hosp Clinico Univ de Salamanca RECRUITING Salamanca 37007 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field